Consistent with the slightly lower mean BP values achieved by olmesartan medoxomil 20 mg/day + hydrochlorothiazide ... or definitely related to study drug was low (6.4%). Serious adverse events ...

At subsequent 4-week intervals, the regimen was modified in patients with blood pressure >130/85 mm Hg: up-titration of olmesartan medoxomil to 40 mg/d; addition of hydrochlorothiazide 12.5 mg/d ...

When a medication works right, it boosts your health or helps you feel better. But a drug can bring on problems if it doesn't mix well with something else you put into your body, like another ...

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...

The results of the RELIEVE UCCD study in patients with moderate-to-severe ulcerative colitis (UC) and Crohn's disease suggest a "best-in-class potential" for the drug, which Sanofi licensed from ...

Nokia's latest mobile launch is the T21. The tablet comes with a 10.36-inch touchscreen display with a resolution of 1200 pixels by 2000 pixels. The Nokia T21 is powered by 1.8GHz MHz octa-core Unisoc ...

It has launched a whole range of Android powered smartphones. Oppo's latest mobile launch is the Pad 4 Pro. The tablet was launched in 11th April 2025. The tablet comes with a 13.20-inch touchscreen ...

Non-Commercial (NC): Only non-commercial uses of the work are permitted. The main purpose of this study was to design and develop a solid self-nanoemulsifying drug delivery system (S-SNEDDS) for the ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...